Credit Sector:- Health Care
Country:- United States
Bond Document:- https://www.bondpdf.com
In order to view the complete data, please login here
Announcement Date | CA Type | CA Impact | CA Event | ISIN |
---|---|---|---|---|
13-Dec-2018 | New Bond | - | - | US584688AJ43 |
Medicines Company/The has issued USD 172500M, 3.50% fixed rate bond due 15-Jan-2024. | ||||
08-Jan-2018 | Asset Sale | - | - | US00214WAE12 |
Medicines Company/The announced today that it has sold its infectious disease business unit to Melinta Subsidiary Corp. | ||||
29-Nov-2017 | Propose Asset Sale | - | - | US00214WAE12 |
Medicines Company/The announced today that it has signed an agreement to sell its infectious disease business to Melinta Subsidiary Corp. | ||||
31-Aug-2015 | Purchase Stock | Target Name | Eshelman Ventures, LLC | US00214WAE12 |
Eshelman Ventures, LLC today announced that it has acquired 944,537 shares of common stock of Medicines Company/The. | ||||
18-Dec-2015 | Propose Asset Sale | - | - | US00214WAE12 |
Medicines Company/The today announced that it has agreed to sell its Hemostasis Portfolio to Mallinckrodt plc. |
All of the financial data available on this page is sourced from FactEntry.